Your browser doesn't support javascript.
loading
Synergy between scientific advancement and technological innovation, illustrated by a mechanism-based model characterizing sodium-glucose cotransporter-2 inhibition.
Zhang, Liping; Ng, Chee M; List, James F; Pfister, Marc.
Affiliation
  • Zhang L; Discovery Medicine and Clinical Pharmacology, Bristol-Myers Squibb, Princeton, New Jersey, USA. liping.zhang3@bms.com
J Clin Pharmacol ; 50(9 Suppl): 113S-120S, 2010 Sep.
Article in En | MEDLINE | ID: mdl-20881224

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus, Type 2 / Sodium-Glucose Transporter 2 Inhibitors / Hypoglycemic Agents Limits: Humans Language: En Journal: J Clin Pharmacol Year: 2010 Document type: Article Affiliation country: United States Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus, Type 2 / Sodium-Glucose Transporter 2 Inhibitors / Hypoglycemic Agents Limits: Humans Language: En Journal: J Clin Pharmacol Year: 2010 Document type: Article Affiliation country: United States Country of publication: United kingdom